Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other

References

• Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966; 241: 2746–2751
   PubMed Web of Science ®Google Scholar
• Stoj C, Kosman DJ. Cuprous oxidase activity of yeast Fet3p and human ceruloplasmin: implication for function. FEBS Lett 2003; 554: 422–426
   PubMed Web of Science ®Google Scholar
• Young SN, Curzon G. A method for obtaining linear reciprocal plots with caeruloplasmin and its application in a study of the kinetic parameters of caeruloplasmin substrates. Biochem J 1972; 129: 273–283
   PubMedGoogle Scholar
• Inoue K, Akaike T, Miyamoto Y, Okamoto T, Sawa T, Otagiri M, Suzuki S, Yoshimura T, Maeda H. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem 1999; 274: 27069–27075
   PubMed Web of Science ®Google Scholar
• Kim IG, Park SY. Requirement of intact human ceruloplasmin for the glutathione-linked peroxidase activity. FEBS Lett 1998; 437: 293–296
   PubMed Web of Science ®Google Scholar
• Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RTA, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995; 92: 2539–2543
   PubMed Web of Science ®Google Scholar
• Vassiliev V, Harris ZL, Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Rev 2005; 49: 633–640
   PubMedGoogle Scholar
• Goldstein IM, Kaplan HB, Edelson HS, Weissmann G. Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals. Ann NY Acad Sci 1982; 389: 368–379
   PubMed Web of Science ®Google Scholar
• Atanasiu RL, Stea D, Mateescu MA, Vergely C, Dalloz F, Briot F, Maupoil V, Nadeau R, Rochette L. Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem 1998; 189: 127–135
   PubMed Web of Science ®Google Scholar
• Agner K. Verdoperoxidase. A ferment isolated from leukocytes. Acta Physiol Scand 1941; A2(Suppl. 8)1–62
   Google Scholar
• Blair-Johnson M, Fiedler T, Fenna R. Human myeloperoxidase: structure of a cyanide complex and its interaction with bromide and thiocyanate substrates at 1.9 Å resolution. Biochemistry 2001; 4: 13990–13997
   Google Scholar
• Klebanoff SJ. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 1968; 95: 2131–2138
   PubMed Web of Science ®Google Scholar
• Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med 1998; 76: 676–681
   PubMed Web of Science ®Google Scholar
• Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67: 1828–1836
   PubMed Web of Science ®Google Scholar
• Arnhold J, Osipov AN, Spalteholz H, Panasenko OM, Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med 2001; 31: 1111–1119
   PubMed Web of Science ®Google Scholar
• Panasenko OM, Spalteholz H, Schiller J, Arnhold J. Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radic Biol Med 2003; 34: 553–562
   PubMed Web of Science ®Google Scholar
• Schiller J, Arnhold J, Gründer W, Arnold K. The action of hypochlorous acid on polymeric components of cartilage. Biol Chem Hoppe Seyler 1994; 375: 167–172
   PubMed Web of Science ®Google Scholar
• Aruoma OI, Halliwell B. Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochem J 1987; 248: 973–976
   PubMed Web of Science ®Google Scholar
• Sharonov BP, Govorova NJU, Lyzlova SN. A comparative study of serum proteins ability to scavenge active oxygen species: O2- and OCl-. Biochem Int 1988; 17: 783–790
   PubMedGoogle Scholar
• Hawkins CL, Davies MJ. Hypochlorite-induced damage to DNA, RNA, and polynucleotides: formation of chloramines and nitrogen-centered radicals. Chem Res Toxicol 2002; 15: 83–92
   PubMed Web of Science ®Google Scholar
• Govorova NIU, Sharonov BP, Lyzlova SN. Erythrocyte oxidative damage by myeloperoxidase. The protective action of serum proteins. Biull Eksp Biol Med 1989; 107: 428–430
   Google Scholar
• Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994; 94: 437–444
   PubMed Web of Science ®Google Scholar
• Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 1996; 97: 1535–1544
   PubMed Web of Science ®Google Scholar
• Kettle AJ, Chan T, Osberg I, Senthilmohan R, Chapman AL, Mocatta TJ, Wagener JS. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 2004; 170: 1317–1323
   PubMed Web of Science ®Google Scholar
• Carr AC, Myzak MC, Stocker R, McCall MR, Frei B. Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett 2000; 487: 176–180
   PubMed Web of Science ®Google Scholar
• Zheng L, Nukuna B, Brennan M-L, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004; 114: 529–541
   PubMed Web of Science ®Google Scholar
• Govorova NIU, Sharonov BP, Iankovskii OIU, Lyzlova SN. Inactivation of active forms of oxygen generated by myeloperoxidase and serum proteins. Dokl Akad Nauk SSSR 1986; 290: 480–483
   Google Scholar
• Yea CM, Dularay B, Elson CJ. Identification of a myeloperoxidase inhibitor from normal human serum. Clin Exp Immunol 1991; 84: 347–352
   Google Scholar
• Segelmark M, Persson B, Hellmark T, Wieslander J. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?. Clin Exp Immunol 1997; 108: 167–174
   PubMed Web of Science ®Google Scholar
• Park YS, Suzuki K, Mumby S, Taniguchi N, Gutteridge JMC. Antioxidant binding of caeruloplasmin with myeloperoxidase: myeloperoxidase is inhibited, but oxidase, peroxidase and and immunoreactive properties of caeruloplasmin remain intact. Free Radic Res 2000; 33: 261–265
   PubMed Web of Science ®Google Scholar
• Griffin SV, Chapman PT, Lianos EA, Lockwood CM. The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int 1999; 55: 917–925
   PubMed Web of Science ®Google Scholar
• Sokolov AV, Pulina MO, Ageeva KV, Runova OL, Zakharova ET, Vasilyev VB. Identification of leukocyte cationic proteins that interact with ceruloplasmin. Biochemistry (Moscow) 2007; 72: 872–877
   PubMed Web of Science ®Google Scholar
• Kokryakov VN. Biology of antibiotics of animal origin. Nauka, St. Petersburg 1999
   Google Scholar
• Sokolov AV, Pulina MO, Ageeva KV, Ayrapetov MI, Berlov MN, Volgin GN, Markov AG, Yablonsky PK, Kolodkin NI, Zakharova ET, Vasilyev VB. Interaction of ceruloplasmin, lactoferrin and myeloperoxidase. Biochemistry (Moscow) 2007; 72: 409–415
   PubMed Web of Science ®Google Scholar
• Sokolov AV, Zakharova ET, Shavlovskii MM, Vasil'ev VB. Isolation of stable human ceruloplasmin and its interaction with salmon protamine. Bioorg Khim 2005; 31: 269–279
   PubMedGoogle Scholar
• Freinstein G, Janoff A. A rapid method of purification of human granulocyte cationic neutral proteases: purification and further characterization of human granulocyte elastase. Biochim Biophys Acta 1975; 403: 493–505
   Google Scholar
• Atassi MZ, Manshouri T. Design of peptide enzymes (pepzymes): Surface-simulation synthetic peptides that mimic the chymotrypsin and trypsin active sites exhibit the activity and specificity of the respective enzyme. Proc Natl Acad Sci USA 1993; 90: 8282–8286
   Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of Bacteriophag. Nature (London) 1970; 227: 680–686
   PubMed Web of Science ®Google Scholar
• Reszka KJ, McCormick ML, Britigan BE. Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubicin and doxorubicin. Biochemistry 2001; 40: 15349–15361
   PubMed Web of Science ®Google Scholar
• Prozorovski VN, Rashkovetski LG, Shavlovski MM, Vasiliev VB, Neifakh SA. Evidence that human ceruloplasmin molecule consists of homologous parts. Int J Pept Protein Res 1982; 19: 40–53
   Google Scholar
• Panasenko OM, Chekanov AV, Vlasova II, Sokolov AV, Ageeva KV, Pulina MO, Cherkalina OS, Vasilyev VB. A study of the effect of ceruloplasmin and lactoferrin on chlorination activity of leukocytic myeloperoxidase using chemiluminescence method. Biofizika 2008; 53: 573–581
   PubMedGoogle Scholar
• Ehrenwald E, Fox PL. Isolation of nonlabile human ceruloplasmin by chromatographic removal of a plasma metalloproteinase. Arch Biochem Biophys 1994; 309: 392–395
   Google Scholar
• Sang QA. Specific proteolysis of ceruloplasmin by leukocyte elastase. Biochem Mol Biol Int 1995; 37: 573–581
   Google Scholar
• Furtmüller PG, Zederbauer M, Jantschko W, Helm J, Bogner M, Jakopitsch C, Obinger C. Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem Biophys 2006; 445: 199–213
   PubMed Web of Science ®Google Scholar
• Zaitsev VN, Zaitseva I, Papiz M, Lindley PL. An X-ray crystallographic study of the binding center of azide inhibitor and organic substrates of ceruloplasmin, a multi-copper oxidase in plasma. J Biol Inorg Chem 1999; 4: 579–587
   PubMed Web of Science ®Google Scholar
• Candeias LP, Stratford MR, Wardman P. Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanide, a model iron (II) complex. Free Radic Res 1994; 20: 241–249
   PubMed Web of Science ®Google Scholar
• Gitlin JD. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem 1988; 263: 6281–6287
   PubMed Web of Science ®Google Scholar